ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

A Year at NCI: Harold Varmus Reflects On Provocative Questions, The Duke Scandal, Financial Disaster And Grant Review

July 22, 2011

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977